This Week in Cardiology cover image

June 16 This Week in Cardiology

This Week in Cardiology

00:00

SODA Glyphlosin: A New SGLT-2 Inhibitor

FDA approved a new SGLT-2 inhibitor called SODA Glyphlosin. The drug is indicated to reduce the risk of cardiovascular death and heart failure hospitalizations in adults with heart failure or diabetes, CKD, and other cardiovascular risk factors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app